Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02986516 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease

Study acronym: SACRO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Sep 2025 to Dec 31, 2026v15
  2. Primary and study completion dates: Sep 2024 to Sep 2025v14
  3. Site details revised at 2 of 28 sitesv13
  4. Primary completion date: Sep 2021 to Sep 2024
    • Study completion date: Sep 2022 to Sep 2024
    • Site details revised at 3 of 28 sites
    v12
  5. Study sites: 25 to 28v11
Show 9 earlier versionsHide 9 earlier versions
  1. Re-verified, no change to tracked fieldsv10
  2. Study sites: 24 to 25v9
  3. Site details revised at 4 of 24 sitesv8
  4. Study sites: 22 to 24v7
  5. Study sites: 21 to 22v6
  6. Study sites: 20 to 21v5
  7. Site contacts updated at 1 of 20 sitesv4
  8. Site details revised at 4 of 20 sitesv3
  9. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 2016 to Mar 16, 2017
    • Secondary endpoints: details revised at 5 of 9 entries
    • Site details revised at 20 of 20 sites
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Comparative study on surgery versus definitive radiation therapy in primary localized sacral chordoma
Trial Details
NCT Number NCT02986516
Lead Sponsor Italian Sarcoma Group
Conditions
(from sponsor)		 Chordoma
Related terms Chordoma
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov